Join to View Full Profile
12902 Usf Magnolia DrMdc 44Tampa, FL 33612
Phone+1 813-745-4673
Dr. Antonia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1994- Yale-New Haven Medical Center (St. Raphael)Residency, Internal Medicine, 1989 - 1991
- Yale-New Haven Medical CenterInternship, Internal Medicine, 1989 - 1990
Uconn School Of MedicineClass of 1989
Certifications & Licensure
NC State Medical License 2018 - 2026
FL State Medical License 1995 - 2020
CT State Medical License 1991 - 1995
WI State Medical License 1990 - 1991
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014, 2016
Clinical Trials
- PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung Start of enrollment: 2023 May 16
Roles: Contact
Publications & Presentations
PubMed
- Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study.Eziafa I Oduah, Tian Zhang, Sin-Ho Jung, Thomas E Stinchcombe, Neal Ready
Future Oncology. 2026-04-01 - Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.Sandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi, Zarifa Gahramanli Ozturk, Theresa A Boyle
Cancer Research. 2026-03-02 - Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.Nicholas DeVito, Erica Gray, Daniel Schrum, Scott Antonia
Journal of Clinical Oncology. 2026-03-01
Press Mentions
Building Better ImmunotherapyJune 25th, 2025- Developing New Tools to Fight CancerOctober 17th, 2022
- Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory BoardJune 8th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
